clevor
orion corporation - ropinirole hidroklorid - dopaminergičnih agenti, agonisti dopamina - psi - indukcijsko bruhanja pri psih.
azilect
teva b.v. - razagilin - parkinsonova bolezen - anti-parkinsonska zdravila - azilect je indiciran za zdravljenje idiopatske parkinsonove bolezni (pd) kot samostojno zdravljenje (brez levodope) ali kot dodatno zdravljenje (z levodopo) pri bolnikih z nihanji na koncu odmerka.
rasagiline mylan
mylan pharmaceuticals limited - razagilinijev tartrat - parkinsonova bolezen - anti-parkinsonska zdravila - rasagilin mylan je indiciran za zdravljenje idiopatske parkinsonove bolezni (pd) kot monoterapijo (brez levodope) ali kot dodatno zdravljenje (z levodopo) pri bolnikih s končno nihanjem odmerka.
rasagiline ratiopharm
teva b.v. - razagilin - parkinsonova bolezen - anti-parkinsonska zdravila - rasagiline izkazala družba ratiopharm je indicirano za zdravljenje idiopatsko parkinsonovo boleznijo (pb) kot monoterapijo (brez levodopo) ali kot dodatna terapija (z levodopo) pri bolnikih s koncem odmerek nihanja.
revolade
novartis europharm limited - eltrombopag - purpura, trombocitopenična, idiopatska - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 in 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 in 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
protaminijev sulfat leo pharma 1400 anti-heparin i.e./ml raztopina za injiciranje ali infundiranje
leo pharma a/s - protamininijev sulfat - raztopina za injiciranje/infundiranje - protamininijev sulfat 10 mg / 1 ml - protamin
protaminijev sulfat leo pharma 1400 anti-heparin i.e./ml raztopina za injiciranje ali infundiranje
leo pharma a/s - protamininijev sulfat - raztopina za injiciranje/infundiranje - protamininijev sulfat 10 mg / 1 ml - protamin
insuman
sanofi-aventis deutschland gmbh - insulin human - sladkorna bolezen - zdravila, ki se uporabljajo pri diabetesu - diabetes mellitus, kjer je potrebno zdravljenje z insulinom. insuman hitro je tudi primeren za zdravljenje hiperglikemično komi in ketoacidoze, kot tudi za doseganje pred, znotraj - in pooperativne stabilizacije pri bolnikih s sladkorno boleznijo.
clivarin 1432 i.e. anti-xa/0,25 ml raztopina za injiciranje
abbott laboratories d.o.o. - natrijev reviparinat - raztopina za injiciranje - natrijev reviparinat 1432 anti-xa i.e. / 0,25 ml - reviparin
clivarin 3436 i.e. anti-xa/0,6 ml raztopina za injiciranje
abbott laboratories d.o.o. - natrijev reviparinat - raztopina za injiciranje - natrijev reviparinat 3436 anti-xa i.e. / 0,6 ml - reviparin